Keywords
Antimicrobials
Xuebijing
Efficacy
Submitted : 2024-06-23
Accepted : 2024-07-08
Published : 2024-07-23
Abstract
Objective: To analyze the therapeutic effect of Xuebijing + antimicrobials in intensive care unit (ICU) patients with severe pneumonia. Methods: 60 ICU patients with severe pneumonia from June 2021 to June 2023 were selected and divided by the random number table method, with 30 cases in each group. The observation group received Xuebijing + antimicrobial treatment, while the control group received only antimicrobial treatment. The differences in rehabilitation indexes, test indexes, and inflammation indexes were compared between the two groups. Results: Mechanical ventilation time, fever reduction time, cough relief time, and hospitalization time of the observation group were significantly shorter than those of the control group (P < 0.05); C-reactive protein, procalcitonin, and white blood cell count of the observation group were significantly lower than those of the control group (P < 0.05); interleukin-6 and tumor necrosis factor-α of the observation group were significantly lower than those of the control group (P < 0.05). Conclusion: The treatment of severe pneumonia patients in ICU with Xuebijing + antibacterial drugs can reduce inflammation, enhance immune function, shorten the pneumonia recovery time, and reduce the adverse reactions of severe pneumonia.
References
Zhao Q, Liang M, Meng Q, 2023, Clinical effect Of Xuebijing Combined with Antibiotics in the Treatment of Severe Pneumonia. Research on Chinese and Foreign Medicine, 2(10): 45–47.
Liu S, Liu X, 2023, Clinical Effect of Xuebijing Injection in Treating Severe Pneumonia in ICU. Journal of Clinical Rational Use of Drugs, 16(1): 58–60.
Mametsayidi A, Patosi, Maimeti A, 2023, Study on the Effect of Xuebijing Combined with Antibiotics in the Treatment of Severe Pneumonia. Chinese Science and Technology Journal Database (Full Text Version) Medicine and Health, 2(10): 36–39.
Pei C, 2023, Study on the Clinical Effectiveness of Xuebijing Combined with Antibiotics in the Treatment of Patients with Severe Pneumonia in ICU. China Science and Technology Journal Database Medicine, 3(7): 42–45.
Rao X, 2023, Analysis of the Clinical Efficacy of Xuebijing Combined with Antibiotics in Patients with Severe Pneumonia in ICU. China Modern Drug Application, 17(18): 113–115.
Liu X, Liu Z, 2023, Analysis of the Clinical Efficacy of Xuebijing Combined with Antibiotics in the Treatment of Patients with Severe Pneumonia in ICU. Chinese Science and Technology Journal Database (Full Text Version) Medicine and Health, 2(11): 88–91.
Jing L, 2022, Study on the Clinical Value of Xuebijing Combined with Antibiotics in the Treatment of Severe Pneumonia. China Modern Drug Application, 16(17): 29–31.
Xie J, Zhang H, 2021, Study on the Effect of Xuebijing Injection + Antibacterial Drugs in the Treatment of Severe Pneumonia. Primary Medical Forum, 25(25): 3644–3646.
Zhang W, 2022, Discussion on Xuebijing Combined with Antibiotics in the Treatment of Severe Pneumonia in ICU. Chinese Science and Technology Journal Database (Digest Edition) Medicine and Health, 2022(1): 75–77.
Lu P, Xu S, Huang B, 2021, Analysis of the Clinical Effect of Xuebijing Combined with Antibiotics in the Treatment of Severe Pneumonia in ICU. Clinical Medical Engineering, 28(12): 1651–1652.